Structure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D Ligands
The activating immunoreceptor NKG2D promotes elimination of infected or malignant cells by cytotoxic lymphocytes through engagement of stress-induced MHC class I-related ligands. The human cytomegalovirus (HCMV)-encoded immunoevasin UL16 subverts NKG2D-mediated immune responses by retaining a select group of diverse NKG2D ligands inside the cell. We report here the crystal structure of UL16 in complex with the NKG2D ligand MICB at 1.8 Å resolution, revealing the molecular basis for the promiscuous, but highly selective, binding of UL16 to unrelated NKG2D ligands. The immunoglobulin-like UL16 protein utilizes a three-stranded β-sheet to engage the α-helical surface of the MHC class I-like MICB platform domain. Intriguingly, residues at the center of this β-sheet mimic a central binding motif employed by the structurally unrelated C-type lectin-like NKG2D to facilitate engagement of diverse NKG2D ligands. Using surface plasmon resonance, we find that UL16 binds MICB, ULBP1, and ULBP2 with similar affinities that lie in the nanomolar range (12–66 nM). The ability of UL16 to bind its ligands depends critically on the presence of a glutamine (MICB) or closely related glutamate (ULBP1 and ULBP2) at position 169. An arginine residue at this position however, as found for example in MICA or ULBP3, would cause steric clashes with UL16 residues. The inability of UL16 to bind MICA and ULBP3 can therefore be attributed to single substitutions at key NKG2D ligand locations. This indicates that selective pressure exerted by viral immunoevasins such as UL16 contributed to the diversification of NKG2D ligands.
Vyšlo v časopise:
Structure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D Ligands. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000723
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000723
Souhrn
The activating immunoreceptor NKG2D promotes elimination of infected or malignant cells by cytotoxic lymphocytes through engagement of stress-induced MHC class I-related ligands. The human cytomegalovirus (HCMV)-encoded immunoevasin UL16 subverts NKG2D-mediated immune responses by retaining a select group of diverse NKG2D ligands inside the cell. We report here the crystal structure of UL16 in complex with the NKG2D ligand MICB at 1.8 Å resolution, revealing the molecular basis for the promiscuous, but highly selective, binding of UL16 to unrelated NKG2D ligands. The immunoglobulin-like UL16 protein utilizes a three-stranded β-sheet to engage the α-helical surface of the MHC class I-like MICB platform domain. Intriguingly, residues at the center of this β-sheet mimic a central binding motif employed by the structurally unrelated C-type lectin-like NKG2D to facilitate engagement of diverse NKG2D ligands. Using surface plasmon resonance, we find that UL16 binds MICB, ULBP1, and ULBP2 with similar affinities that lie in the nanomolar range (12–66 nM). The ability of UL16 to bind its ligands depends critically on the presence of a glutamine (MICB) or closely related glutamate (ULBP1 and ULBP2) at position 169. An arginine residue at this position however, as found for example in MICA or ULBP3, would cause steric clashes with UL16 residues. The inability of UL16 to bind MICA and ULBP3 can therefore be attributed to single substitutions at key NKG2D ligand locations. This indicates that selective pressure exerted by viral immunoevasins such as UL16 contributed to the diversification of NKG2D ligands.
Zdroje
1. ReddehaseMJ
2002 Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2 831 844
2. LanierLL
2008 Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8 259 268
3. LodoenMB
LanierLL
2006 Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18 391 398
4. BironCA
ByronKS
SullivanJL
1989 Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320 1731 1735
5. JonjicS
BabicM
PolicB
KrmpoticA
2008 Immune evasion of natural killer cells by viruses. Curr Opin Immunol 20 30 38
6. PowersC
DeFilippisV
MalouliD
FruhK
2008 Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325 333 359
7. WilkinsonGW
TomasecP
StantonRJ
ArmstrongM
Prod'hommeV
2008 Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 41 206 212
8. LodoenMB
LanierLL
2005 Viral modulation of NK cell immunity. Nat Rev Microbiol 3 59 69
9. LjunggrenHG
KarreK
1990 In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 11 237 244
10. DengL
MariuzzaRA
2006 Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors. Semin Immunol 18 159 166
11. LanierLL
2008 Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9 495 502
12. VivierE
TomaselloE
BaratinM
WalzerT
UgoliniS
2008 Functions of natural killer cells. Nat Immunol 9 503 510
13. GonzalezS
GrohV
SpiesT
2006 Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol 298 121 138
14. RauletDH
2003 Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3 781 790
15. BauerS
GrohV
WuJ
SteinleA
PhillipsJH
1999 Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 727 729
16. WuJ
SongY
BakkerAB
BauerS
SpiesT
1999 An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285 730 732
17. EagleRA
TrowsdaleJ
2007 Promiscuity and the single receptor: NKG2D. Nat Rev Immunol 7 737 744
18. CosmanD
MullbergJ
SutherlandCL
ChinW
ArmitageR
2001 ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 123 133
19. EagleRA
TraherneJA
HairJR
JafferjiI
TrowsdaleJ
2009 ULBP6/RAET1L is an additional human NKG2D ligand. Eur J Immunol
20. DunnC
ChalupnyNJ
SutherlandCL
DoschS
SivakumarPV
2003 Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197 1427 1439
21. WelteSA
SinzgerC
LutzSZ
Singh-JasujaH
SampaioKL
2003 Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33 194 203
22. ChalupnyNJ
Rein-WestonA
DoschS
CosmanD
2006 Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun 346 175 181
23. JonjicS
PolicB
KrmpoticA
2008 Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance? Eur J Immunol 38 2952 2956
24. Stern-GinossarN
ElefantN
ZimmermannA
WolfDG
SalehN
2007 Host immune system gene targeting by a viral miRNA. Science 317 376 381
25. HolmesMA
LiP
PetersdorfEW
StrongRK
2002 Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D. J Immunol 169 1395 1400
26. LiP
MorrisDL
WillcoxBE
SteinleA
SpiesT
2001 Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2 443 451
27. LiP
WillieST
BauerS
MorrisDL
SpiesT
1999 Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity 10 577 584
28. RadaevS
RostroB
BrooksAG
ColonnaM
SunPD
2001 Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15 1039 1049
29. SpreuJ
StehleT
SteinleA
2006 Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their alpha2 domains. J Immunol 177 3143 3149
30. ChalupnyNJ
SutherlandCL
LawrenceWA
Rein-WestonA
CosmanD
2003 ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun 305 129 135
31. WittenbrinkM
SpreuJ
SteinleA
2009 Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain. Eur J Immunol
32. RobinsonJ
WallerMJ
FailSC
McWilliamH
LopezR
2009 The IMGT/HLA database. Nucleic Acids Res 37 D1013 1017
33. KayeJ
BrowneH
StoffelM
MinsonT
1992 The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro. J Virol 66 6609 6615
34. StanleyP
1989 Chinese hamster ovary cell mutants with multiple glycosylation defects for production of glycoproteins with minimal carbohydrate heterogeneity. Mol Cell Biol 9 377 383
35. BorkP
HolmL
SanderC
1994 The immunoglobulin fold. Structural classification, sequence patterns and common core. J Mol Biol 242 309 320
36. HarpazY
ChothiaC
1994 Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J Mol Biol 238 528 539
37. HalabyDM
PouponA
MornonJ
1999 The immunoglobulin fold family: sequence analysis and 3D structure comparisons. Protein Eng 12 563 571
38. BahadurRP
ZachariasM
2008 The interface of protein-protein complexes: analysis of contacts and prediction of interactions. Cell Mol Life Sci 65 1059 1072
39. LawrenceMC
ColmanPM
1993 Shape complementarity at protein/protein interfaces. J Mol Biol 234 946 950
40. McFarlandBJ
StrongRK
2003 Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation. Immunity 19 803 812
41. StebbinsCE
GalanJE
2001 Structural mimicry in bacterial virulence. Nature 412 701 705
42. AlcamiA
2003 Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3 36 50
43. LambrisJD
RicklinD
GeisbrechtBV
2008 Complement evasion by human pathogens. Nat Rev Microbiol 6 132 142
44. van CleefKW
SmitMJ
BruggemanCA
VinkC
2006 Cytomegalovirus-encoded homologs of G protein-coupled receptors and chemokines. J Clin Virol 35 343 348
45. YangZ
BjorkmanPJ
2008 Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci U S A 105 10095 10100
46. AlexanderJM
NelsonCA
van BerkelV
LauEK
StudtsJM
2002 Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111 343 356
47. CarfiA
SmithCA
SmolakPJ
McGrewJ
WileyDC
1999 Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc Natl Acad Sci U S A 96 12379 12383
48. McFarlandBJ
KortemmeT
YuSF
BakerD
StrongRK
2003 Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands. Structure 11 411 422
49. EmsleyP
CowtanK
2004 Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60 2126 2132
50. MansJ
ZhiL
RevillezaMJ
SmithL
RedwoodA
2009 Structure and function of murine cytomegalovirus MHC-I-like molecules: how the virus turned the host defense to its advantage. Immunol Res 43 264 279
51. SmithHR
HeuselJW
MehtaIK
KimS
DornerBG
2002 Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99 8826 8831
52. KrmpoticA
HasanM
LoewendorfA
SauligT
HaleniusA
2005 NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 201 211 220
53. LodoenMB
AbenesG
UmamotoS
HouchinsJP
LiuF
2004 The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 200 1075 1081
54. LenacT
ArapovicJ
TravenL
KrmpoticA
JonjicS
2008 Murine cytomegalovirus regulation of NKG2D ligands. Med Microbiol Immunol 197 159 166
55. PerssonBD
MullerS
ReiterDM
SchmittBB
MarttilaM
2009 An arginine switch in the species B adenovirus knob determines high-affinity engagement of cellular receptor CD46. J Virol 83 673 686
56. KabschW
1993 Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. Journal of Applied Crystallography 26 795 800
57. Collaborative Computational Project N 1994 The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50 760 763
58. TerwilligerT
2004 SOLVE and RESOLVE: automated structure solution, density modification and model building. J Synchrotron Radiat 11 49 52
59. AdamsPD
Grosse-KunstleveRW
HungLW
IoergerTR
McCoyAJ
2002 PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58 1948 1954
60. PainterJ
MerrittEA
2006 Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr 62 439 450
61. VriendG
1990 WHAT IF: a molecular modeling and drug design program. J Mol Graph 8 52 56, 29
62. KabschW
SanderC
1983 Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22 2577 2637
63. DeLanoWL
2002 The Pymol Molecular Graphics System.
64. Bohne-LangA
von der LiethCW
2005 GlyProt: in silico glycosylation of proteins. Nucleic Acids Res 33 W214 219
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 1
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils
- CD8+ T Cell Control of HIV—A Known Unknown
- Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis
- The Deadly Chytrid Fungus: A Story of an Emerging Pathogen